Drug class
Dopamine D2 receptor antagonist; gastrointestinal prokinetic and antiemetic
Mechanism of action
Antagonises dopamine D2 receptors in the chemoreceptor trigger zone and enteric nervous system, reducing nausea and vomiting and enhancing gastrointestinal motility.
General use cases
- Symptomatic treatment of nausea, vomiting and functional dyspepsia or delayed gastric emptying in countries where clebopride products are authorised; current availability and duration restrictions are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
